Embody logo

Embody Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10

Best for: low flat-rate compounded GLP-1 pricing at every dose

7.8
★★★★☆3.9/5

Price is where Embody scores best in our breakdown.

Semaglutide

$79/mo

Tirzepatide

$129/mo

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation. Aggressive flat-rate pricing with all 50 states and a 24/7 clinician messaging model led by a board-certified internal medicine CMO.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedOral OptionSemaglutideTirzepatideAll 50 States24/7 Messaging

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Embody logo
3.9 / 5
Our editorial rating
Visit Embody →

from $79/mo · no insurance needed

Embody at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$79/mo
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored Embody

Each dimension is scored algorithmically from Embody’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

8.8/10

At $79/mo, Embody runs about 53% below the $169 median for GLP-1 providers.

Effectiveness25%

7.9/10

Embody offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.5/10

Online intake and platform experience — ongoing clinician messaging, consult included in the price; 6 platform features disclosed.

Trust & Safety15%

7.5/10

Core details confirmed by our editors; no FDA warning letters on file; discloses which pharmacy makes its medication.

Accessibility10%

8.0/10

Embody treats patients in all 50 states.

Support10%

6.1/10

Clinician messaging between visits.

6scored dimensions
641providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Embody review

Last checked August 2026
  • Confirmed current pricing across 4 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Verified the compounding pharmacy partner and its accreditation
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$79–$329/mo across 4 dose/plan tiers — checked July 2026
FDA warning-letter register
No letter on file for this provider
Compounding pharmacy partners
RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, Triad Rx

What to expect when you sign up with Embody

We walked Embody’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Medical intake questionnaire — health history, goals, and starting weight, completed online.
  2. 2Checkout — you choose a plan and pay before the eligibility consult (the clinician review happens after checkout).
  3. 3Telehealth consultation — an OpenLoop Health licensed clinician reviews your information and decides whether a compounded GLP-1 is appropriate.
  4. 4If approved, medication ships with free expedited delivery; you re-report weight every 3-4 weeks.
Price shown before you start
  • Lowest entry pricing in the compounded segment — an intro offer (e.g. 'Save $200 instantly') brings the first month down; confirm the ongoing monthly price, which is higher than the promo.
  • Like its sister platform, you pay at checkout BEFORE the eligibility consult; the clinician review determines whether you qualify.
  • Async telehealth — no baseline labs or live video visit required, so it's quick to start, with a lighter clinical touch than lab-gated providers.
  • Embody advertises a 100% satisfaction refund policy tied to progress in the first 6 months — a results-based guarantee, though the exact terms are worth reading before relying on it.
  • Free expedited shipping is included, and Embody says it uses certified compounding pharmacies; care is delivered by OpenLoop Health clinicians.

GLP-1 medications Embody offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Peptides Embody offers

Beyond GLP-1s, Embody also offers these peptides — tap any for our evidence-based guide.

Pricing

Prices re-verified

Injection — flat at every doseCompounded
$79/mo
semaglutide

Checkout: '$79/mo flat forever' (strikethrough $299); bundles $76/$73/$69 per month on 3/6/12-mo. CAVEAT: T&C list price is $199/mo — the $79 depends on the auto-applied SUMMER promo marketed as permanently locked; Trustpilot complaints allege the lock was not always honored.

Injection — flat at every doseCompounded
$129/mo
tirzepatide

Checkout tile 'Flat rate at $119/month (strikethrough $349)'; homepage 'starting at $129/month'; bundles $126/$123/$119 per month.

OralCompounded · oral
$229/mo
semaglutide

New oral semaglutide $229/mo.

Oral / gumCompounded · oral
$329/mo
tirzepatide

Oral tirzepatide $329/mo; gum bundles to $299/mo at 12-month.

Ready to get started?

Plans and promotions change often — check Embody's current pricing and active discounts before you decide.

See Embody pricing →

Embody compounding-pharmacy partners

Each partner below is a 503A or 503B pharmacy that Embody routes prescriptions through.

Health Warehouse

Precision Compounding Pharmacy

Compare every compounding pharmacy we’ve reviewed →

What we like

  • Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Watch-outs

  • The $79 rate is an auto-applied promo 'locked forever'; the terms list $199/mo and reviewers allege the lock isn't honored
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide has no FDA-approved counterpart, and oral GLP-1 bioavailability is still clinically debated

Embody at a glance: the cheapest sticker price in the market, with the caveats to match

Embody — the storefront trades as "Em" at joinem.co, run by a Delaware company called Modern Metabolic Medicine, Inc. — currently posts the lowest ongoing price on this site for compounded semaglutide: $79 a month, marketed as "flat forever," against a category median around $169. That is not a first-month teaser stepping up later; the marketed rate is the same every month, at every dose, with medication, the clinician consult, and overnight shipping bundled in. On raw value, nothing in our rankings beats it right now. The reason Embody still doesn't run away with the category is everything around the price: promotional fine print doing quiet work, a checkout that charges your card before a clinician has reviewed anything, and review-badge conduct you should see before typing in a card number.

The pricing — genuinely excellent, with one piece of fine print you must read

Four programs, all flat monthly rates with no dose-based escalation: semaglutide injection at $79, tirzepatide injection at $129, oral semaglutide at $229, and the compounded oral tirzepatide gum at $329. Every tier includes all doses, the medical consult, and expedited shipping — no membership fee on top — and HSA/FSA cards are accepted. The fine print on the headline number: Embody's own terms and conditions still carry a semaglutide list price roughly two and a half times the marketed rate. The $79 you see at checkout rides an auto-applied promotional discount that the marketing describes as permanently locked in. If that lock holds, the deal is as good as it looks. But Trustpilot complaints allege the lock hasn't always been honored — subscribers describing renewals billed above the rate they signed up at. No outsider can adjudicate individual billing disputes. But when the discount lives in promotional fine print rather than the list price, your protection is a screenshot: capture the "flat forever" checkout language the day you order, and check your first few renewal charges.

  • Semaglutide injection: $79/month, marketed as flat forever at every dose — promo-dependent; see the fine-print caveat above.
  • Tirzepatide injection: $129/month flat, all doses.
  • Oral semaglutide: $229/month.
  • Oral tirzepatide gum: $329/month — the needle-free differentiator almost nobody else offers.
  • Included in every tier: all doses, clinician consult, overnight shipping; HSA/FSA accepted, no contract.

Medications and pharmacies — transparency has genuinely improved

Everything here is compounded — you will not get brand-name Ozempic, Wegovy, Zepbound, or Mounjaro through Embody, which is normal at this price tier but means the products aren't FDA-reviewed the way brand drugs are. The meaningful change: Embody now names its compounding pharmacy partners at checkout — RedRock Pharmacy, Health Warehouse, Precision Compounding, and Triad Rx — where it previously disclosed none. That resolves the biggest old transparency objection and lets you look up the pharmacy actually dispensing your medication. The oral tirzepatide gum remains the catalog's one real oddity: a needle-free format with no FDA-approved counterpart, priced above the injectable, built on oral peptide absorption the clinical literature still treats as an open question. Defensible if injecting is a hard no; wrong if you're optimizing for cost or the most established route.

The trust file — read this section before you check out

This is where Embody earns the lowest trust marks of any provider still worth calling a legitimate option. Three things you'll see at checkout. First, the checkout displays an "Excellent 4.8" Trustpilot-style badge — while Embody's actual Trustpilot rating is 3.6 across 1,833 reviews, 26% of them one-star. Presenting a rating that flatters the real one by more than a full point, in Trustpilot's visual language, should make you discount everything else the marketing says. Second, a countdown timer ("approval valid 14:59") starts running before any clinician has reviewed your intake — manufactured urgency around a medical decision, since no real approval exists yet to expire. Third, despite a banner reading "You Don't Pay a Dime If Not Approved," your card is charged in full at checkout, before the medical review; the refund comes only if a clinician disqualifies you or the medication is never dispensed. Pay-then-review is a standard telehealth model — but the banner implies the opposite sequence. On the credit side: medical leadership sits with Dr. Alan Viglione, MD, board-certified in internal medicine; 24/7 clinician messaging is included; there are no FDA warning letters; the black-box warning is disclosed prominently; and a 6-month satisfaction guarantee backs the program. How we weigh dark patterns against clinical substance is laid out in our scoring methodology.

Who should choose Embody — and who should skip it

Choose Embody if price is your binding constraint and you go in with eyes open. At $79 a month all-in for semaglutide, it is the cheapest credible way on this site to be on a GLP-1 right now, available in all 50 states. Named pharmacies and physician-led oversight put real clinical substance behind the discount. Just buy defensively — screenshot the locked-rate language, ignore the countdown, and expect your card to be charged before the consult. It's also the pick if you want the needle-free tirzepatide gum, which almost no one else sells. Skip it if you want brand-name medication, if you'd rather pay a moderate premium to a provider whose marketing you never have to fact-check, or if a misleading review badge at checkout is disqualifying on principle. That's a hard position to argue with.

Bottom line

Embody is the strange case of best-in-market pricing attached to the weakest conduct record among providers still listed here. It's $79 flat semaglutide, all-inclusive, with named pharmacies. And it's sold through a checkout with an inflated review badge, a fake-urgency timer, and a pay-before-consult flow dressed up as its opposite. It's a real bargain that demands a skeptical buyer. Judge it on the recurring charge that actually hits your card, keep your screenshots, and treat the 6-month guarantee as a backstop, not a reason to relax.

Shopping around? Ivim Health ($75/month) and Collective ($59/month) are the nearest alternatives to Embody in our rankings.

The Bottom Line

Price is where Embody scores best in our breakdown.

Score: 7.8/10Best for: low flat-rate compounded GLP-1 pricing at every doseFrom: $79/mo

Ready to start with Embody?

Starting at $79/month. See current pricing and start your free consultation.

Embody might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider Ivim Health.

Alternatives to Embody

8.1/ 10
Verified partner

GobyMeds

Best for: budget-conscious shoppers

★★★★☆4.1/5

Editorial score · methodology

$93/mosemaglutide
$133/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full GobyMeds review →
7.7/ 10
Verified partner

Ivim Health

Best for: budget-conscious shoppers

★★★★☆3.9/5

Editorial score · methodology

$75/mosemaglutide
$149/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinFDA Warning
Get StartedRead full Ivim Health review →
6.2/ 10
Verified partner

Wellorithm

Best for: compounded GLP-1 access with oral tablet options across 49 states

★★★☆☆3.1/5

Editorial score · methodology

$147/mosemaglutide
$247/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Wellorithm review →

Frequently Asked Questions

Embody (operated by Modern Metabolic Medicine, Inc.) displays a LegitScript certification seal and partners with OpenLoop Health for its licensed clinician network. The live site names four pharmacy partners - RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx - which is more dispensing transparency than most compounded GLP-1 platforms provide. The company also backs its program with a 6-month satisfaction guarantee: follow the plan and see no meaningful progress, and Embody commits to making it right.
Embody (marketed as 'Em' at joinem.co) is a telehealth weight-loss program from Modern Metabolic Medicine, Inc. that offers compounded semaglutide and tirzepatide injections alongside a unique compounded oral tirzepatide gum formulation - a delivery format designed for patients who prefer not to self-inject. Medical leadership is provided by Dr. Alan Viglione, board-certified in Internal Medicine; clinician care is delivered through the OpenLoop Health network. The service is available in all 50 states with no insurance required.
Embody uses intro pricing for the first month followed by a regular rate. Based on our review data, first-month pricing starts at $99 for semaglutide and $149 for tirzepatide injections; regular monthly pricing runs $299 per month for injection plans ongoing. The compounded oral tirzepatide gum is $329 per month. Embody periodically runs promotional rates, so current pricing on their site may differ - always confirm before enrolling. Medication, unlimited clinician messaging, and free expedited shipping are bundled into the monthly price.
Yes - Embody offers compounded semaglutide and compounded tirzepatide in subcutaneous injection form, plus a compounded oral tirzepatide gum formulation that is uncommon among telehealth GLP-1 platforms. These are compounded preparations of the active GLP-1 ingredients, not FDA-approved brand-name drugs (Wegovy, Ozempic, Zepbound, Mounjaro) - Embody discloses this explicitly on its medication safety page. The oral tirzepatide gum is a less common delivery format; its bioavailability profile differs from the injectable formulations studied in brand-name clinical trials.
Every Embody plan includes the compounded GLP-1 medication, unlimited 24/7 clinician messaging and dose-adjustment support, a personalized treatment plan, and free expedited delivery - with no hidden fees. The program is backed by a 6-month satisfaction guarantee, and consultations are bundled into the monthly price rather than billed separately. The oral tirzepatide gum ($329/mo) is a separate option from the injection plans but carries the same clinician support and shipping model.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: The $79 rate is an auto-applied promo 'locked forever'; the terms list $199/mo and reviewers allege the lock isn't honored; Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option; Pharmacy partners not publicly named — compounding source transparency is limited; Compounded oral tirzepatide has no FDA-approved counterpart, and oral GLP-1 bioavailability is still clinically debated. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Embody review:

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Embody's current pricing

Plans start at $79/month. Start your free consultation to check eligibility and today's price.